Artiva Biotherapeutics Inc
Research Artiva Biotherapeutics Inc (ARTV) on Bullrun: market cap USD 338.62M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerARTV
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 338.62M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 25.01M
- Free cash flow-USD 20.77M
Valuation Snapshot
latest market cap is USD 338.62M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 83.87M | -USD 79.34M | n/a | -3.43 | USD 26.70M | USD 10.94M | USD 109.97M |
| FY2024 | USD 251.00K | -USD 65.37M | -USD 55.67M | n/a | -5.81 | USD 40.24M | USD 14.35M | USD 186.64M |
| FY2023 | USD 32.92M | -USD 28.72M | -USD 50.69M | n/a | -35.78 | USD 53.50M | USD 16.91M | -USD 162.02M |
| FY2022 | USD 4.93M | -USD 60.98M | -USD 57.13M | n/a | -6.51 | USD 102.53M | USD 19.45M | -USD 140.70M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 338.62M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 105.30M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 244.86M | n/a | n/a | n/a |
About Artiva Biotherapeutics Inc
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.
Related stock research
Other Healthcare stocks
Aardvark Therapeutics Inc (AARD)
Abeona Therapeutics Inc (ABEO)
Acumen Pharmaceuticals Inc (ABOS)
Absci Corp (ABSI)
Arbutus Biopharma Corp (ABUS)
ABVC BioPharma Inc (ABVC)
Acadia Pharmaceuticals Inc (ACAD)
Adicet Bio Inc (ACET)
Achieve Life Sciences Inc (ACHV)
Alpha Cognition Inc (ACOG)
Aclaris Therapeutics Inc (ACRS)
Acrivon Therapeutics Inc (ACRV)
Frequently asked questions
What is Artiva Biotherapeutics Inc's market cap?
Artiva Biotherapeutics Inc's market capitalization is USD 338.62M.
What does Artiva Biotherapeutics Inc do?
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.